DiaMedica Therapeutics Inc.
DMAC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001401040
No open-market purchases or sales by DiaMedica Therapeutics Inc. insiders were filed in the last 90 days; 88 institutions reported holding it in 13F filings for Q2 2026, worth $87.8M in total; no superinvestor holds it.
13F holders, Q3 2023
Institutional positions in DiaMedica Therapeutics Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 36
- +4 vs. Q2 2023
- Shares held
- 4.25M
- +760.1K (+21.8%) vs. Q2 2023
- Total value
- $11.0M
- −$4.11M (−27.3%) vs. Q2 2023
- New holders
- 6
- 12 more added
- Sold out
- 2
- 7 more reduced
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting DMAC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 88 | $87.8M |
| Q1 2026 | 99 | $79.2M |
| Q4 2025 | 92 | $96.0M |
| Q3 2025 | 78 | $82.8M |
| Q2 2025 | 58 | $34.2M |
| Q1 2025 | 57 | $28.5M |
| Q4 2024 | 45 | $36.5M |
| Q3 2024 | 40 | $23.3M |
| Q2 2024 | 32 | $14.9M |
| Q1 2024 | 32 | $12.7M |
| Q4 2023 | 38 | $10.9M |
| Q3 2023 | 36 | $11.0M |
| Q2 2023 | 32 | $15.1M |
| Q1 2023 | 25 | $3.93M |
| Q4 2022 | 28 | $3.99M |
| Q3 2022 | 26 | $3.14M |
| Q2 2022 | 28 | $7.42M |
| Q1 2022 | 34 | $10.0M |
| Q4 2021 | 39 | $14.9M |
| Q3 2021 | 34 | $11.2M |
| Q2 2021 | 43 | $16.9M |
| Q1 2021 | 41 | $52.1M |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding DiaMedica Therapeutics Inc.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Toronto Dominion Bank | 24 | $62 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 25 | $65 | 0.00% | +4+19.0% | Added |
| UBS Group AG | 84 | $217 | 0.00% | +84 | New |
| Wells Fargo & Company | 163 | $421 | 0.00% | +47+40.5% | Added |
| Federation des caisses Desjardins du Quebec | 230 | $593 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 805 | $2.00K | 0.00% | −79−8.9% | Reduced |
| Simplex Trading, LLC | 1,020 | $2.00K | 0.00% | +818+405.0% | Added |
| Legend Financial Advisors, Inc. | 1,000 | $2.58K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 1,000 | $2.58K | 0.00% | +999+99,900.0% | Added |
| TD Waterhouse Canada Inc. | 1,570 | $4.81K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 3,761 | $9.70K | 0.00% | −2,479−39.7% | Reduced |
| US Bancorp | 4,335 | $11.2K | 0.00% | 00.0% | Unchanged |
| Massmutual Trust Co FSB | 4,824 | $12.4K | 0.00% | 00.0% | Unchanged |
| Charles Schwab Investment Management Inc | 13,251 | $34.2K | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 14,000 | $36.1K | 0.00% | +4,200+42.9% | Added |
| Citadel Advisors LLC | 15,868 | $40.9K | 0.00% | +7,956+100.6% | Added |
| Dimensional Fund Advisors LP | 16,959 | $43.8K | 0.00% | 00.0% | Unchanged |
| Stonebridge Capital Advisors LLC | 20,000 | $51.6K | 0.01% | +20,000 | New |
| Marshall Wace, LLP | 26,745 | $69.0K | 0.00% | +26,745 | New |
| Millennium Management LLC | 28,672 | $74.0K | 0.00% | +28,672 | New |
| Bank of New York Mellon Corp | 34,617 | $89.3K | 0.00% | −1,277−3.6% | Reduced |
| Catalyst Financial Partners LLC | 36,267 | $93.6K | 0.03% | 00.0% | Unchanged |
| State Street Corp | 66,629 | $171.9K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 89,700 | $231.4K | 0.00% | +7,540+9.2% | Added |
| Morgan Stanley | 93,800 | $242.0K | 0.00% | +36,700+64.3% | Added |
| BlackRock Inc. | 101,725 | $262.5K | 0.00% | +29,810+41.5% | Added |
| Aristides Capital LLC | 106,333 | $274.3K | 0.18% | +106,333 | New |
| First Manhattan Co | 114,744 | $296.0K | 0.00% | −10,000−8.0% | Reduced |
| Jacob Asset Management of New York LLC | 168,730 | $435.3K | 0.61% | −30,000−15.1% | Reduced |
| EAM Investors, LLC | 212,512 | $548.3K | 0.11% | −57,907−21.4% | Reduced |
| Geode Capital Management, LLC | 218,778 | $564.6K | 0.00% | +33,908+18.3% | Added |
| Bleichroeder LP | 222,317 | $573.6K | 0.14% | −71,800−24.4% | Reduced |
| Paragon Associates & Paragon Associates II Joint Venture | 470,000 | $1.21M | 3.97% | +145,000+44.6% | Added |
| Altium Capital Management LP | 496,000 | $1.28M | 0.74% | +496,000 | New |
| Vanguard Group Inc | 788,789 | $2.04M | 0.00% | +5,800+0.7% | Added |
| Cooperman Leon G | 875,993 | $2.26M | 0.12% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −16,923−100.0% | Sold out |
| Signaturefd, LLC | 0 | $0 | 0.00% | −25−100.0% | Sold out |